Anonymous v Takeda: Sponsorship of diabetes ‘One Stop Shops’ (no breach)

📊

Key facts

⌄

Case number	AUTH/2243/6/09
Parties	Anonymous v Takeda
Issue	Sponsorship of diabetes “One Stop Shops” (third-party annual review service)
Complaint received	17 June 2009
Case completed	14 July 2009
Applicable Code year	2008
Alleged clauses referenced	Clauses 2, 9.1, 15.2, 18.1 and 18.4
Panel decision	No breach of the Code (including no breach of Clause 2)
Key Panel considerations	Takeda appeared to have little involvement beyond funding; no evidence of inducement to prescribe; no evidence the service failed therapeutic review programme criteria; no evidence of representative misconduct; complainant provided no evidence and was anonymous/non-contactable
Sanctions	None stated
Appeal	No appeal

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

An anonymous, non-contactable complainant raised concerns about Takeda UK’s sponsorship (funding) of third-party diabetes “One Stop Shops” intended to complete annual diabetes checks in one appointment.
Concerns included: ability to verify professional credentials of staff (eg chiropodist, dietician, retinal screener); whether the service was agreed with local consultants and local prescribing protocols; who would manage titration of medicines; follow-up arrangements; and whether the service was exclusive or limited to certain patient groups.
The complainant also questioned the independence of the provider because it was run/directed by a former Takeda employee, and suggested the sponsorship might be driven by return on investment rather than patient outcomes.
Takeda provided its contract with the third party and the One Stop Shop protocol, stating its role was solely financial support as a “service to medicine”, with no sales involvement and no link to use of any particular medicine.
The third party was responsible for promoting the service to the NHS and contracted separately with NHS providers; Takeda was not a party to those NHS contracts.
Takeda stated the service was a therapy review programme: any medicine change required GP authorisation/sign-off; follow-up remained with the patient’s own health professional; and the third party warranted staff were trained/accredited and appropriately insured.

⚖️

⌄

No breach of the Code was ruled.
The Panel found no evidence that the arrangements amounted to an inducement to prescribe a specific medicine (Clause 18.1) or failed to meet the criteria for a therapeutic review programme (Clause 18.4).
No evidence was provided that Takeda representatives failed to comply with the Code or that high standards were not maintained (Clauses 9.1 and 15.2).
No breach of Clause 2 was ruled.

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access